© 2026 Sinochem Nanjing Corporation,
All Right Reserved
3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin belongs to the larger family of coumarin derivatives, showing up as a specialty chemical with unique applications in pharmaceuticals and advanced research. Taking a close look at its makeup, the compound links a bromobiphenyl group with a hydroxycoumarin core and includes a hydroxy-substituted phenylpropyl moiety; this combination brings along interesting physical and chemical behaviors. The raw material forms a solid at room temperature, offering flexibility for storage and handling in laboratory settings and production lines. Its pale, off-white to faint yellow flakes or powder appear dense, with minimal dust generation, which gives technicians greater safety when preparing stock solutions or measuring precise quantities for syntheses. Conserving material integrity becomes easier during transport due to its stability as a non-volatile solid.
Chemists classify this molecule under the coumarin scaffold, but the presence of a large brominated aromatic system and extra phenyl groups leads to increased molecular weight and lipophilicity. The molecular formula, C30H23BrO3, reflects an arrangement that increases both synthetic complexity and biological activity, a reason why similar structures keep drawing attention in drug design and biochemistry. Bonding across the coumarin ring and bromobiphenyl arms impacts electronic distribution, solubility, and reactivity, which underpins how it performs both as a research reagent and a synthetic intermediate. X-ray diffraction studies on single crystals have revealed tightly packed arrays due to π-π interactions from the extended aromaticity. Such features determine both the crystal habit—often as blocks or thick, plate-like structures—and the measured density, which can approach or exceed 1.30 g/cm³, depending on purity and form.
Handling this compound brings the benefit of a broad melting range, which reflects moderate thermal stability and absence of hazardous fumes at conventional operating temperatures. Its solid form may show up in tightly bound flakes or as a free-flowing powder, which feeds right into precision applications, either for manual measurement or automated dispensing in multi-gram syntheses. Raw material arrives tightly sealed and dry, so operators don't deal with premature clumping or caking issues. Crystals show sparkle under the microscope, and the powder scatters light less aggressively than typical pharmaceutical-grade fine chemicals, signaling lower moisture absorption. Dissolution rates increase in organic solvents—such as DMSO or chloroform—owing to the extended π-system and relative nonpolarity. That means research and R&D professionals can prepare clear, stable solutions for chromatography or structure-activity studies without prolonged agitation.
In supply chains, material purity ranks high; products for research or synthesis often feature assay values above 98%. Residual solvents, unreacted precursors, and trace metal content require tight monitoring to guarantee downstream efficacy, especially in pharmaceutical labs designing structure–activity relationships. Typical packaging options include amber glass bottles or sturdy polymeric containers, each labeled with proper HS Code: 2932.20.9090, which ties the product to coumarin derivatives for both customs and regulatory purposes. Whenever densification or particle sizing features arise as concerns, vacuum packing under inert gas reduces risk of oxidation and humidity pickup, which is crucial for maintaining reactivity and reducing variability. Reagent-grade batches include certificates of analysis with NMR, HPLC, and IR verification, letting every project start with known-quality inputs.
Research and translational teams depend on this compound to explore new anticoagulant, anti-inflammatory, and anticancer agents. The core coumarin ring sits at the center of established pharmaceuticals, and smart modifications—such as the aromatic substitutions found here—help discover new leads or fine-tune target affinity. Dense powders like this usually get suspended in organic media for screening, and their solution stability under laboratory lighting means shelf life isn't compromised during repeated use. Easy-to-handle flakes work well in glovebox operations, where static and microclumping can stop other fine materials from reliable mixing. As with all specialty materials, keeping operations tidy, dry, and free from cross-contamination remains a key safety measure; technicians wear gloves, use local ventilation, and avoid food or drink in storage and handling zones.
Though formulated for laboratory and preclinical use, 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin bears handling risks common to halogenated organic solids. Dust inhalation, skin contact, or accidental ingestion remains possible during weighing or transfer. Standard protocols include nitrile gloves, lab coats, and either fume hoods or ventilated enclosures to contain airborne traces. Eye protection and ready access to eyewash stations provide further layers of safety for both new and experienced personnel. Waste is handled as both halogenated and coumarin-containing organic material, restricted under both EU and US hazardous waste codes. Labels advise against sewer discharge, and containers must be kept closed in dedicated chemical storage areas. Transport follows regulated lines as an organic chemical of moderate hazard, and safety datasheets recommend measures in line with OSHA and REACH global requirements.
The push for new anticoagulants and targeted pharmaceuticals drives suppliers to innovate with specialty coumarins and their derivatives. The challenging synthesis and purification steps bring calls for improved, safer, and more sustainable processes upstream, such as greener reagents, energy-saving crystallization, and modular packaging to cut waste. Since research often requires grams-to-kilogram scale, ensuring repeatable, traceable supply chains offers both confidence and compliance for therapeutic development. Collaborations with academic, contract, and pharmaceutical labs ensure learnings pass rapidly from bench to clinical studies, speeding discovery and regulatory approval. Investments in improved analytical validation—such as broader NMR libraries, deeper mass spectrometry panels, and live digital traceability—strengthen the field and support advances in both chemical synthesis and health sciences.
